HopeStage
Back to all studies
CompletedNCT01149577

Olanzapine and Sleep Patterns in Schizophrenia

About this titleRead the official source — NCT01149577
Medication studyAges 18–45India
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 45 years. Other eligibility criteria applied.

What did participation involve?

The study group receives olanzapine as a study medication.

Listed locations
RanchiSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2007
Recruitment status
Completed
Enrollment listed in the registry
25
Sponsor
Central Institute of Psychiatry, Ranchi, India
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
India
Age range
From 18 Years to 45 Years
Official registry ID
NCT01149577
Official title
Show the full official title

Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia Patients

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Ranchi

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Central Institute of Psychiatry, Ranchi, India, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Olanzapine.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 45 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies